Blog - Page 243 of 264 - Cactus three

Investors Plough .1 Billion Into AI Startups Despite Economic Struggles

05

Jul

Science and Technology

Investors Plough $27.1 Billion Into AI Startups Despite Economic Struggles

Related media - Latest news In May, CoreWeave, a provider of cloud computing services for AI companies, raised $1.1 billion, followed by $7.5 billion in debt, reaching a valuation of $19 billion. Scale AI, a data provider for AI companies, secured $1 billion, at a valuation of $13.8 billion. Additionally, xAI, founded by Elon Musk, raised $6 billion, reaching a valuation of $24 billion. According to Kyle Stanford, research analyst at PitchBook, these funding rounds have increased overall deal volume in the industry, both in terms of dollar amounts and number of deals. "It's not declining anymore," he said. "The…

Remembering Ann Lurie: From Nurse to Renowned Philanthropist

03

Jul

By Benjamin Hall

Health

Remembering Ann Lurie: From Nurse to Renowned Philanthropist

Related media - News 24 hours Ann Lurie, a former pediatric nurse turned prominent Chicago philanthropist, died Monday at her home. She was 79. Northwestern University, where Lurie was a trustee and major donor, announced her death without giving a cause. Raised in Miami by a single mother, Lurie was an only child and protested the Vietnam War during her college years. She initially planned to join the Peace Corps, but instead married Robert H. Lurie. Robert Lurie built a large real estate and investment business with Sam Zell, which included holdings such as The Chicago Tribune and the Chicago…

Robots Have Chubby Faces (and Smiles), According to New Research

03

Jul

By Benjamin Hall

Science and Technology

Robots Have Chubby Faces (and Smiles), According to New Research

More news - News 24 hours In Japan, engineers are working to create robots that can mimic human expressions, particularly smiles. They developed a face mask using human skin cells, which they attached to robots using a new technique that hides the bond and is flexible enough to form expressions such as a grimace or a slight smile. The look is a mix between the disturbing Hannibal Lecter mask and the claymation character Gumby. However, scientists believe that these prototypes could lead to more advanced robots. These robots would have a durable, elastic outer layer that protects the machine while…

New COVID-19 vaccines recommended for all Americans 6 months and older this fall

01

Jul

By Benjamin Hall

Health

New COVID-19 vaccines recommended for all Americans 6 months and older this fall

More news - Recent news The Centers for Disease Control and Prevention (CDC) announced Thursday that all Americans aged 6 months and older should receive one of the new COVID-19 vaccines as soon as they become available this fall. This recommendation comes amid a summer surge in COVID-19 cases, with infection rates rising in at least 39 states and territories. While most Americans have developed some immunity to the coronavirus through previous infections or vaccinations, the new vaccines offer an incremental boost. However, their effectiveness wanes over a few months as immunity wanes and the virus continues to mutate. Data…

Nvidia, with a market capitalization of .34 trillion, becomes the most valuable company

01

Jul

By Benjamin Hall

Science and Technology

Nvidia, with a market capitalization of $3.34 trillion, becomes the most valuable company

More news - News 24 hours Nvidia leapfrogged two of the tech industry’s most storied names on Tuesday to become the world’s most valuable public company, according to data from S&P Global. Its rise has been fueled by a boom in generative artificial intelligence and growing demand for the company’s chips — known as graphics processing units, or GPUs — that enable the creation of AI systems. Nvidia's rise is among the fastest in the history of the market. Just two years ago, the company's market valuation exceeded $400 billion. Now, in the span of a year, it has gone…

Rising Drug Costs: Are Pharmaceutical Benefit Managers to Blame?

29

Jun

By Benjamin Hall

Health

Rising Drug Costs: Are Pharmaceutical Benefit Managers to Blame?

More news - Recent news For many Americans, the rising tide of prescription drug prices seems like a relentless force, threatening to swamp family budgets and access to health care. While pharmaceutical companies often assume public responsibility, the web of influences on drug costs is much more intricate. Today we shine our spotlight on a critical, but typically hidden, player in this system: pharmacy benefit managers, or PBMs. Rebecca Robbins, a leading investigative reporter specializing in pharmaceuticals for the New York Times, takes us on a deep dive into the world of PBMs. We explore their role as middlemen between…